Skip to main content

Advertisement

Table 1 Psychotropic drugs and FDA labeled psychiatric uses in youth.*

From: Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring

Class, Subclass Drug Age Limits, yr. Indication
Stimulants    
  Amphetamines 3+ ADHD; Narcolepsy
  Methylphenidate 6+ ADHD; Narcolepsy
  Modafinil 16+ Narcolepsy
Antidepressants    
SSRI    
  Fluoxetine 8+ Depression
   7+ OCD
  Fluvoxamine 8+ OCD
  Sertraline 6+ OCD
TCA    
  Clomipramine 10+ OCD
  Doxepin 12+ Depression
  Impiramine 6+ Enuresis
   12+ Depression
Antipsychotics    
Conventional    
  Chlorpromazine 6 (mo)-12 Severe Behavior Problems; Psychosis
  Haloperidol 3+ Tourette's Disorder; Psychosis; Severe Behavioral Disorders
  Thiothixene 12+ Psychosis
  Loxapine 16+ Psychosis
  Molindone 12+ Psychosis
  Fluphenazine 12+ Psychosis
  Trifluperazine 12+ Psychosis
  Perphenazine 12+ Schizophrenia
  Pimozide 12+ Tourette's Disorder
  Prochlorperazine 2–12 Psychosis
  Thioridazine 2+ Schizophrenia
Atypical    
  Aripiprazole 13+ Schizophrenia
   10+ Acute and Mixed Mania
  Risperidone 10+ Acute and Mixed Mania;
   5–16 Irritability in Autism
   13+ Schizophrenia
Miscellaneous    
  Atomoxetine 6+ ADHD
  Chlordiazepoxide 6+ Anxiety
  Clorazepate 10+ Anxiety
  Desmopressin Oral 6+ Enuresis
  Diazepam 6 months + Anxiety
  Flurazepam 15+ Insomnia
  Hydroxyzine < 6 Anxiety
   > 6 Sedation
  Lithium Carbonate 12+ Manic Episodes
  Promethazine 2+ Sedation
  1. *This information was current on March 12, 2008 based on the Physicians Desk Reference 2007 or FDA announcements. Readers should consult FDA guidelines for most current drug labeling.